However, current and next-gen obesity therapeutics have the potential to vastly improve health outcomes
In the STEP and SURMOUNT trials: Constipation was reported in up to 24% of patients on semaglutide 18-23% of patients on tirzepatide experienced constipation It is one of the top three side effects of these medications and is more frequent in those who: Lose weight rapidly Eat low-fiber diets Are female (due to hormonal factors affecting gut motility) Conventional Treatment Approaches Most providers recommend over-the-counter (OTC) remedies such as: Stool softeners (docusate) Fiber supplements (psyllium, methylcellulose) Laxatives (PEG 3350, senna, Mag Citrate) These can help in the short term but do not address the root cause
pharmacy in June, which led to an adverse reaction in the patient
Throughout the trial, the participants reported their daily alcohol intake using a highly validated tracking method
Review and Adjustment: Check the calculated charge rate against the manufacturers recommendations or industry standards for safety
Solenos stock soared 40% after the FDA nod and has held fairly steady since, with the company valued at nearly $4 billion as of early June
.png)
